Nir Naor's most recent trade in Neuronetics Inc was a trade of 500,000 Common Stock done . Disclosure was reported to the exchange on July 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neuronetics Inc | Nir Naor | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 500,000 | 500,000 (2%) | 2% | 0 | Common Stock | |
| Brainstorm Cell Therapeutics | Nir Naor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
| Axogen Inc | Nir Naor | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.22 per share. | 06 Jan 2025 | 39,132 | 260,868 (0%) | 0% | 15.2 | 595,589 | Common Stock |
| Brainstorm Cell Therapeutics | Nir Naor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 30,666 | 31,465 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc | Naor Nir | CFO | 01 Jan 2024 | 300,000 | 300,000 (0%) | 0% | - | Common Stock | ||
| Brainstorm Cell Therapeutics | Nir Naor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2023 | 11,999 | 11,999 (0%) | 0% | 0 | Common Stock |